The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...

A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...

The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...

The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy ...

It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.

The FDA proposed discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed, because it 'is not ...

In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...

Oral phenylephrine, a common nasal-congestion ingredient in over-the-counter drugs, shouldn't be used in monograph drug products, the Food and Drug Administration is proposing. The agency said a ...

Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...